The FDA's action on Seldane leaves you in an awkward position
The FDA's action on Seldane leaves you in an awkward position.
There have been hundreds of reports of arrhythmias and sudden death associated with Seldane (terfenadine). The FDA says it's no longer worth the risk...now that Allegra is on the market.
Allegra (fexofenadine) is the active metabolite of Seldane...it's just as effective, but without the cardiac risk.